At the close of 2020, the U.S. Congress passed the No Surprises Act to end the pernicious practice of so-called surprise billing for out-of-network care. But the country’s recent experience with balance-billing prohibitions for Covid-19 testing and treatment offers an ominous warning. The…
Read the full post on The New England Journal of Medicine: Search Results in Health Policy
